The William Harvey Research Institute (WHRI) is a world leading Pharmacological Centre with a vibrant, multidisciplinary scientific environment devoted to therapeutic innovation in cardiovascular, endocrine and inflammatory diseases. Our major strength is in bringing scientists with different skills together, combining disciplines ranging from genetics, cell biology, pharmacology, epidemiology, advanced imaging and clinical trials with therapeutic innovation.


Latest news

Obesity leads to harmful activation of the immune system
Researchers find link between a high-fat diet, obesity and cardiovascular disease risk.

William Harvey New Year Celebration 2017
On Friday the 3rd of February the WHRI held its annual New Year Celebration and featured 15 talks from the institute's postgraduates and young post-docs.

Genetic defect found to cause disease in multiple organs
New research from Queen Mary University of London (QMUL) has identified a novel syndrome in patients with kidney and adrenal disease.

New genes for height revealed in global study of 700,000 people
Over 80 new genetic variants that strongly influence human height have been discovered in a study co-led by Professor Panos Deloukas. 

William Harvey Research Institute hosts Church of England clergy visits
Church of England vicars visit the WHRI to experience clinical and genomic research at first hand, as part of a national initiative to help scientists and faith leaders engage in dialogue and enhance understanding of ethical issues in medicine.


^ Back to Top